Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02836522 · ClinicalTrials.gov registry record
Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 406
- Enrollment target
NCT02836522: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02836522 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 406 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02836522 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 406 participants
- Enrollment target
Study Summary
The purpose of this study is to finalize development of a questionnaire that measures health-related symptoms and concerns for persons diagnosed with, and either treated or monitored for, anal pre-cancer lesions.
Interventions
- BEHAVIORAL Assessment of Health-Related Quality
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 406 participants |
| Start Date | 2016-04-25 |
| Est. Completion | 2023-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02836522
The ClinicalTrials.gov registry entry for NCT02836522 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 406 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Assessment of Health-Related Quality is the first listed.
NCT02836522 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02836522 about?
NCT02836522 is a clinical study titled "Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)". The purpose of this study is to finalize development of a questionnaire that measures health-related symptoms and concerns for persons diagnosed with, and either treated or monitored for, anal pre-cancer lesions.
What is the current status of trial NCT02836522?
This trial is currently completed. The enrollment target is 406 participants. The study started on 2016-04-25. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT02836522?
The interventions under investigation include: Assessment of Health-Related Quality (BEHAVIORAL).
Who is sponsoring clinical trial NCT02836522?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.